title: Changing the face of diabetic care with haptoglobin genotype selection and vitamin e.
abstract: Research over the past 10 years in our laboratory has led to two major findings. The first is that haptoglobin (Hp) genotype can predict the risk of developing vascular complications in individuals with diabetes mellitus (DM), and the second, more far-reaching discovery, is that vitamin E treatment can significantly reduce vascular complications in individuals with DM and the Hp 2-2 genotype. The former finding has been well documented in numerous studies which included over 50,000 patients of diverse geographical and ethnic backgrounds. The latter discovery is more recent and less well accepted by the medical community due to confounding reports over the past 30 years regarding the efficacy of vitamin E treatment for vascular disease. We propose that the benefit of vitamin E treatment was not obvious in earlier studies due to the absence of any genetic basis for patient selection. Our studies dividing DM individuals into vitamin E treatment subgroups based on Hp genotype show a clear benefit for individuals of the Hp 2-2 genotype, while patients carrying the other two Hp genotypes are not affected or may be adversely affected by receiving vitamin E. These findings may explain the overall lack of benefit seen in previous vitamin E studies and emphasize the importance of carefully selecting which patients should receive vitamin E therapy. The pharmacogenomic paradigm discussed in this review potentially could result in a dramatic improvement in the health of millions of individuals worldwide using a treatment that is both accessible and affordable to all.
authors.affiliation: Department of Anatomy, Bruce Rappaport Technion Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
authors.forename: Nina S
authors.initials: NS
authors.lastname: Levy
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Levy
keywords: Haptoglobin; cardiovascular disease; diabetes; genotype; vitamin E
references.citation: Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):341-7
references.pmid: 18032779
references.citation: Blood. 1957 Jun;12(6):493-506
references.pmid: 13436506
references.citation: Circ Res. 2006 Dec 8;99(12):1419-25
references.pmid: 17082477
references.citation: Diabetes. 2008 Oct;57(10):2794-800
references.pmid: 18599520
references.citation: Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):134-40
references.pmid: 17068284
references.citation: Diabetes. 2008 Jun;57(6):1702-6
references.pmid: 18332093
references.citation: Circ Res. 2003 Jun 13;92(11):1193-200
references.pmid: 12750308
references.citation: Blood. 2001 Dec 15;98(13):3693-8
references.pmid: 11739174
references.citation: Immunogenetics. 2001 Mar;53(2):170-7
references.pmid: 11345593
references.citation: J Clin Invest. 1993 Mar;91(3):977-85
references.pmid: 7680672
references.citation: J Am Coll Cardiol. 2007 Jan 2;49(1):82-7
references.pmid: 17207726
references.citation: Circ Res. 2007 Jul 6;101(1):106-10
references.pmid: 17525367
references.citation: Am J Physiol Renal Physiol. 2009 Apr;296(4):F830-8
references.pmid: 19176700
references.citation: Am J Pathol. 2005 Apr;166(4):973-83
references.pmid: 15793279
references.citation: Blood. 1998 Sep 15;92(6):1870-7
references.pmid: 9731043
references.citation: Biochem J. 1955 Dec;61(4):629-41
references.pmid: 13276348
references.citation: J Am Coll Cardiol. 2008 Sep 23;52(13):1049-51
references.pmid: 18848136
references.citation: Circulation. 1999 Aug 3;100(5):547-52
references.pmid: 10430770
references.citation: Clin Chem. 1996 Oct;42(10):1589-600
references.pmid: 8855140
references.citation: Biochemistry. 2004 Apr 6;43(13):3899-906
references.pmid: 15049697
references.citation: Circ Res. 2005 Mar 4;96(4):435-41
references.pmid: 15662028
references.citation: Nature. 1956 Sep 29;178(4535):694-5
references.pmid: 13369501
references.citation: Atherosclerosis. 1999 Aug;145(2):287-92
references.pmid: 10488955
references.citation: J Am Coll Cardiol. 2002 Dec 4;40(11):1984-90
references.pmid: 12475459
references.citation: Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1389-95
references.pmid: 15550518
references.citation: Clin Chem. 2007 Aug;53(8):1397-400
references.pmid: 17644791
references.citation: Atherosclerosis. 2010 Mar;209(1):28-31
references.pmid: 19775690
references.citation: Diabetes. 2005 Sep;54(9):2802-6
references.pmid: 16123372
references.citation: Diabetes Metab Res Rev. 2007 Feb;23(2):152-6
references.pmid: 16742000
references.citation: Atherosclerosis. 2010 Jul;211(1):25-7
references.pmid: 20223458
references.citation: Diabetes Care. 2003 Sep;26(9):2628-31
references.pmid: 12941730
references.citation: Annu Rev Genet. 1986;20:81-108
references.pmid: 2880559
references.citation: Pharmacogenomics. 2010 May;11(5):675-84
references.pmid: 20415560